Similar articles for PMID: 25879549

Year	Number of Results
1978	1
1984	1
1992	1
1994	1
1995	1
1998	1
1999	2
2000	3
2001	4
2002	2
2003	3
2004	2
2005	2
2006	4
2007	4
2008	4
2009	7
2010	9
2011	9
2012	15
2013	13
2014	18
2015	27
2016	25
2017	35
2018	32
2019	38
2020	27
2021	35
2022	19
2023	7
2024	0

1

AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells.

Fan D, Li Z, Zhang X, Yang Y, Yuan X, Zhang X, Yang M, Zhang Y, Xiong D. Fan D, et al. J Hematol Oncol. 2015 Feb 28;8:18. doi: 10.1186/s13045-015-0109-5. J Hematol Oncol. 2015. PMID: 25879549 Free PMC article.

2

A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.

Feuring-Buske M, Frankel AE, Alexander RL, Gerhard B, Hogge DE. Feuring-Buske M, et al. Cancer Res. 2002 Mar 15;62(6):1730-6. Cancer Res. 2002. PMID: 11912147

3

T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia.

Mardiros A, Dos Santos C, McDonald T, Brown CE, Wang X, Budde LE, Hoffman L, Aguilar B, Chang WC, Bretzlaff W, Chang B, Jonnalagadda M, Starr R, Ostberg JR, Jensen MC, Bhatia R, Forman SJ. Mardiros A, et al. Blood. 2013 Oct 31;122(18):3138-48. doi: 10.1182/blood-2012-12-474056. Epub 2013 Sep 12. Blood. 2013. PMID: 24030378 Free PMC article.

4

Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.

Han L, Jorgensen JL, Brooks C, Shi C, Zhang Q, Nogueras González GM, Cavazos A, Pan R, Mu H, Wang SA, Zhou J, Ai-Atrash G, Ciurea SO, Rettig M, DiPersio JF, Cortes J, Huang X, Kantarjian HM, Andreeff M, Ravandi F, Konopleva M. Han L, et al. Clin Cancer Res. 2017 Jul 1;23(13):3385-3395. doi: 10.1158/1078-0432.CCR-16-1904. Epub 2017 Jan 17. Clin Cancer Res. 2017. PMID: 28096272 Free PMC article.

5

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells.

Jin L, Lee EM, Ramshaw HS, Busfield SJ, Peoppl AG, Wilkinson L, Guthridge MA, Thomas D, Barry EF, Boyd A, Gearing DP, Vairo G, Lopez AF, Dick JE, Lock RB. Jin L, et al. Cell Stem Cell. 2009 Jul 2;5(1):31-42. doi: 10.1016/j.stem.2009.04.018. Cell Stem Cell. 2009. PMID: 19570512 Free article.

6

CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.

Bonifant CL, Szoor A, Torres D, Joseph N, Velasquez MP, Iwahori K, Gaikwad A, Nguyen P, Arber C, Song XT, Redell M, Gottschalk S. Bonifant CL, et al. Mol Ther. 2016 Sep 29;24(9):1615-26. doi: 10.1038/mt.2016.116. Epub 2016 Jun 6. Mol Ther. 2016. PMID: 27401038 Free PMC article.

7

Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.

Gill S, Tasian SK, Ruella M, Shestova O, Li Y, Porter DL, Carroll M, Danet-Desnoyers G, Scholler J, Grupp SA, June CH, Kalos M. Gill S, et al. Blood. 2014 Apr 10;123(15):2343-54. doi: 10.1182/blood-2013-09-529537. Epub 2014 Mar 4. Blood. 2014. PMID: 24596416 Free PMC article.

8

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors.

Thokala R, Olivares S, Mi T, Maiti S, Deniger D, Huls H, Torikai H, Singh H, Champlin RE, Laskowski T, McNamara G, Cooper LJ. Thokala R, et al. PLoS One. 2016 Aug 22;11(8):e0159477. doi: 10.1371/journal.pone.0159477. eCollection 2016. PLoS One. 2016. PMID: 27548616 Free PMC article.

9

Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.

Hogge DE, Yalcintepe L, Wong SH, Gerhard B, Frankel AE. Hogge DE, et al. Clin Cancer Res. 2006 Feb 15;12(4):1284-91. doi: 10.1158/1078-0432.CCR-05-2070. Clin Cancer Res. 2006. PMID: 16489085

10

MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+ / CD131- epitope expressed by leukemia stem cells.

Leyton JV, Williams B, Gao C, Keating A, Minden M, Reilly RM. Leyton JV, et al. Leuk Res. 2014 Nov;38(11):1367-73. doi: 10.1016/j.leukres.2014.09.005. Epub 2014 Sep 20. Leuk Res. 2014. PMID: 25278187

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

311 results

Results by year